Research and Development

Our Research and Development (R&D) efforts are dedicated to creating new and innovative pharmaceuticals for the treatment of psychiatric and neurological disorders. Through investment and perseverance, we strive to create the very best treatments for patients.

We are the only fully-integrated pharmaceutical company in the world, solely devoted to the treatment of psychiatric and neurological disorders. We dedicate our entire R&D efforts to develop innovative drugs for treatment of a number of psychiatric and neurological disorders. Our R&D projects focus on: Alzheimer’s disease, Depression, Parkinson’s disease, and Schizophrenia.

Results 1 – 4 of 4 Page 1 of 1

Search results for "". Page 1 of 1, Results 1 to 4 of 4
Title	Location	Country
Title	Location	Country	Reset
QA Academic, CMC QA Academic, CMC Copenhagen, Danish Capital Region, DK Mar 29, 2025 0.00 mi	Copenhagen, Danish Capital Region, DK	Denmark
Senior Medical Science Liaison (MSL) Neurology - South Central Senior Medical Science Liaison (MSL) Neurology - South Central Dallas, TX, US Mar 26, 2025 0.00 mi	Dallas, TX, US	United States
Associate Director Medical Review and Medical Information - Remote opportunity Associate Director Medical Review and Medical Information - Remote opportunity Deerfield, IL, US Mar 15, 2025 0.00 mi	Deerfield, IL, US	United States
Medical Director Global Patient Safety (GPS) US Medical Director Global Patient Safety (GPS) US Deerfield, IL, US Mar 15, 2025 0.00 mi	Deerfield, IL, US	United States